Showing results (31-40 of 94) with videos related to
Sort By:
Pageof 10
Clinical Drug Investigation|May 30, 2007
Safety and tolerability of acarbose in the treatment of type 1 and type 2 diabetes mellitusDieter Neuser, Alice Benson, Andreas Brückner, et al.Journal of Diabetes and Its Complications|March 22, 2016
Lipoprotein composition in patients with type 1 diabetes mellitus: Impact of lipases and adipokinesThomas A Hughes, Rossana M Calderon, Sylvia Diaz, et al.Journal of Clinical Lipidology|July 28, 2012
Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitusRonald B Goldberg, Robert S Rosenson, Eric Hernandez-Triana, et al.Global Heart|February 19, 2015
Metabolic syndrome in andean populationsDiana A Chirinos, Oscar L Morey-Vargas, Ronald B Goldberg, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|April 8, 2017
A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P ComplexCecilia Frej, Armando J Mendez, Mario Ruiz, et al.Journal of Clinical Lipidology|February 5, 2011
Lipoprotein and apolipoprotein ratios in the VYTAL trial of ezetimibe/simvastatin compared with atorvastatin in type 2 diabetesJohn R Guyton, Ronald B Goldberg, Theodore Mazzone, et al.Current Medical Research and Opinion|April 8, 2010
A 26-week, placebo- and pioglitazone-controlled, dose-ranging study of rivoglitazone, a novel thiazolidinedione for the treatment of type 2 diabetesKenneth E Truitt, Ronald B Goldberg, Julio Rosenstock, et al.Diabetes Care|May 15, 2014
Lifestyle and metformin interventions have a durable effect to lower CRP and tPA levels in the diabetes prevention program except in those who develop diabetesRonald B Goldberg, Marinella G Temprosa, Kieren J Mather, et al.Circulation|October 19, 2005
Ability of serum to decrease cellular acylCoA:cholesterol acyl transferase activity predicts cardiovascular outcomesJulio A Chirinos, Juan P Zambrano, Simon Chakko, et al.The Journal of Clinical Endocrinology and Metabolism|May 6, 2015
Elevated Lipoprotein Lipase Activity Does Not Account for the Association Between Adiponectin and HDL in Type 1 DiabetesRossana M Calderon, Sylvia Diaz, Angela Szeto, et al.Pageof 10